相关实验视频
Updated: Jul 18, 2025
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.2K
奥克萨利普拉丁在化疗期间会增加补偿性止痛 - - 一项可行性研究
Carsten Dahl Mørch1,2, Joanna E Szpejewska3,4, Laurids Ø Poulsen3,5
1Center for Neuroplasticity and Pain (CNAP), Aalborg University, Aalborg, Denmark.
Scandinavian journal of pain
|August 19, 2023
概括
抵消性疼痛缓解 (OA) 在氧沙化疗期间意外增加,尽管OA在患有神经病变的患者中通常会减少. 需要进一步的研究来理解这种现象.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
背景情况:
- 补充止痛 (OA) 涉及到感知疼痛强度的不成比例下降,随着热刺激温度的轻微降低.
- 骨关节炎的神经机制很复杂,涉及到外周和中部时过.
- 奥克萨利普拉丁化学疗法通常会诱导外周感官神经病变,其特征是感冒诱导的全神经症.
研究的目的:
- 为了研究氧沙的神经毒性作用对接受辅助化疗的患者的偏移性止痛 (OA) 的影响.
- 在治疗结肠癌的oxaliplatin过程中探索OA的变化.
主要方法:
- 在17名结肠癌患者的评估OA,在12个辅助氧沙治疗周期中进行了评估.
- 量化OA是当温度从46°C降低到45°C时疼痛强度的减少.
- 通过混合效应线性模型分析了OA的变化,并通过Sidak的测试对多次比较进行了校正.
主要成果:
- 与基线相比,第二,第三,第五,第六,第九和第十个治疗周期的补偿止痛 (OA) 显著增加 (p<0.05).
结论:
- 与预期相反,oxaliplatin化疗期间OA增加,与神经病变患者的典型下降不同.
- 在oxaliplatin治疗期间观察到的OA增加需要进一步调查其潜在机制.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
242
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
242
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199